Efficacy and Safety of Unripe Bokbunja Extract on Improvement of Blood Cholesterol
NCT ID: NCT03649620
Last Updated: 2018-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2016-12-31
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava
NCT02091024
Efficacy and Safety of Kochujang Pills on Improvement of Blood Lipids
NCT01735149
Antioxidative Effect of Plantago Asiatica L. Extract
NCT01278589
Evaluation of the Functionality of an Extract Rich in Phytosterols and Phytostanols on Parameters Related to the Lipid Profile of Individuals With Hypercholesterolemia, Mainly in the Levels of Total Cholesterol, LDL Cholesterol and Oxidized LDL
NCT06954649
Efficacy and Safety of Angelica Gigas Nakai and Allium Cepa L.Extract Mixtures on the Improvement of Blood Flow
NCT04389125
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
unripe Bokbunja Extract
tablet(1 tablet/d, 600 mg/d) for 12 weeks
unripe Bokbunja Extract
tablet(1 tablet/d, 600 mg/d) for 12 weeks
Placebo
Placebo for 12 weeks
Placebo
Placebo for 12 weeks
unripe Bokbunja Extract
tablet(1 tablet/d, 600 mg/d) for 12 weeks
Placebo
Placebo for 12 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
unripe Bokbunja Extract
tablet(1 tablet/d, 600 mg/d) for 12 weeks
Placebo
Placebo for 12 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total cholesterol 200-239 mg/dl
* subjects giving written informed consent
Exclusion Criteria
* History of disease that could interfere with the test products or impede their absorption, such as gastrointestinal disease or gastrointestinal surgery
* Participation in any other clinical trials within past 2 months
* Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
* Pregnancy or breast feeding etc,.
20 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jong Ho Lee
Professor, Principal Investigator
References
Explore related publications, articles, or registry entries linked to this study.
Cho JM, Chae J, Jeong SR, Moon MJ, Ha KC, Kim S, Lee JH. The cholesterol-lowering effect of unripe Rubus coreanus is associated with decreased oxidized LDL and apolipoprotein B levels in subjects with borderline-high cholesterol levels: a randomized controlled trial. Lipids Health Dis. 2020 Jul 9;19(1):166. doi: 10.1186/s12944-020-01338-z.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BC_cholesterol
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.